SCHEMBL3075608

SCHEMBL3075608

O=C(O)N1CCN(CCOc2ccc(C3=CCN(C(=O)OCc4ccccc4)CC3)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 1/20 0.51
▸ S1PR3 Q99500 1/20 0.51
▸ LTA4H P09960 2/20 0.49
▸ HTT P42858 1/20 0.49
▸ KCNA5 P22460 4/20 0.47
▸ PPARG P37231 4/20 0.47
▸ PPARA Q07869 4/20 0.47
▸ ALDH1A1 P00352 1/20 0.46
▸ PKM P14618 1/20 0.46
▸ HRH2 P25021 1/20 0.46
▸ HRH1 P35367 1/20 0.46
▸ GRM5 P41594 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.45
▸ LNPEP Q9UIQ6 1/20 0.44
▸ DRD3 P35462 1/20 0.44
▸ ADORA3 P0DMS8 1/20 0.44
▸ HTR2A P28223 1/20 0.44
▸ HTR7 P34969 1/20 0.44
▸ OPRM1 P35372 1/20 0.44
▸ SIGMAR1 Q99720 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL749505 0.89 PPARG (0.47) S1PR1S1PR3LTA4HHTTKCNA5
SCHEMBL3068061 0.88 HRH2 (0.52) S1PR1S1PR3ALDH1A1HRH2HRH1
SCHEMBL13150056 0.81 KCNA5 (0.64) LTA4HHTTKCNA5ALDH1A1PKM
SCHEMBL8315932 0.81 MEN1 (0.57) ALDH1A1GRM5KDM4ELNPEP
SCHEMBL750227 0.81 PRMT5 (0.42) S1PR1S1PR3PPARGPPARAHRH2
SCHEMBL21384574 0.80 TDP1 (0.50) ALDH1A1GRM5KDM4ELNPEP
SCHEMBL749352 0.80 GRM5 (0.54) ALDH1A1GRM5KDM4ELNPEP
SCHEMBL16874748 0.80 PRMT5 (0.56) S1PR1S1PR3HTTALDH1A1KDM4E
SCHEMBL23303045 0.78 HRH2 (0.60) LTA4HHTTKCNA5ALDH1A1PKM
SCHEMBL22563072 0.78 GRM5 (0.52) ALDH1A1GRM5KDM4ELNPEPSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130203714-A1 CHEMICAL COMPOUNDS - 643 ASTRAZENECA R&D (SE) 2013-08-08 — — US disclosed
EP-2396333-B1 TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES AND THEIR USES FOR PROSTATE CANCER ASTRAZENECA AB (SE) 2013-07-03 — — EP disclosed
US-8258140-B2 Chemical compounds—643 ASTRAZENECA AB (SE) 2012-09-04 — — US disclosed
US-20100292222-A1 CHEMICAL COMPOUNDS 751 ASTRAZENECA AB (SE) 2010-11-18 — — US disclosed
US-20100267699-A1 CHEMICAL COMPOUNDS - 643 ASTRAZENECA R&D 2010-10-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292222-A1 CHEMICAL COMPOUNDS 751 AR, NR5A1, KLK3 S1PR1 395/4885S1PR3 469/4885LTA4H 2809/4885
US-20130203714-A1 CHEMICAL COMPOUNDS - 643 AR, KLK3, ESRRA S1PR1 546/4885S1PR3 347/4885LTA4H 2733/4885
US-20100267699-A1 CHEMICAL COMPOUNDS - 643 AR, KLK3, ESRRA S1PR1 613/4885S1PR3 408/4885LTA4H 2529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback